Platelet Aggregation Test with Measles Antigen in Multiple Sclerosis

Panelius, Martin; Myllyla, Gunnar; Penttinen, Kari; Halonen, Pekka; Rinne, U. K.
May 1970
British Medical Journal;5/23/1970, Vol. 2 Issue 5707, p461
Academic Journal
No abstract available.


Related Articles

  • Alternative application options in healthcare. Rajan, J. V. // Chemical Business;Oct2000, Vol. 14 Issue 10, pXXV 

    Describes some alternative applications for previously approved drugs. Aspirin for suppressing platelet aggregation; Colchicine for multiple sclerosis; Minoxidil for baldness; Salbutamol for psoriasis.

  • Aetiology of Optic Neuritis.  // British Medical Journal;8/2/1975, Vol. 3 Issue 5978, p265 

    Examines the etiology of optic neuritis. Clinical manifestations of neurological diseases; Prevalence of measles antibodies in the cerebrospinal fluid in multiple sclerosis; Association of optic neuritis with multiple sclerosis.

  • Multiple Sclerosis and Malabsorption. Gupta, Jagdish K.; Ingegno, Alfred P.; Cook, Albert W.; Pertschuk, Louis P. // American Journal of Gastroenterology;Dec1977, Vol. 68 Issue 6, p560 

    Malabsorption tests were studied in 52 patients with multiple sclerosis. The stools were examined microscopically for fat and undigested meat fibers and were found to be abnormal in 41.6 and 40.9% respectively. Abnormally low five hour excretion of d-xylose was demonstrated in 26.6% cases....

  • Antiviral immune response in patients with multiple sclerosis and healthy siblings. Comabella, M.; Montalban, X.; Horga, A.; Messmer, B.; Kakalacheva, K.; Strowig, T.; Caballero, E.; Münz, C.; Lünemann, J. D. // Multiple Sclerosis (13524585);Mar2010, Vol. 16 Issue 3, p355 

    The objective of this study was to determine the immune responses to candidate viral triggers of multiple sclerosis in patients and healthy siblings raised in the same family household. Virus antigen-specific IgG responses to Epstein-Barr virus-derived gene products as well as to human...

  • How HIITS happens.  // RN;Mar93, Vol. 56 Issue 3, p35 

    Presents the pathophysiology of heparin-induced thrombocytopenia and thrombosis syndrome. Antigen formation; Immunoglobulin G response; Platelet activation and aggregation.

  • Platelet function defects in chronic alcoholism. Mikhailidis, D.P.; Jenkins, W.J.; Barradas, M.A.; Jeremy, J.Y.; Dandona, P. // British Medical Journal (Clinical Research Edition);9/20/1986, Vol. 293 Issue 6549, p715 

    Examines the platelet function defects in chronic alcoholism. Response of platelets to conventional in vitro aggregating agents; Inhibition of platelet aggregation and thromboxane A[sub 2]; Estimation of alcohol consumption prior to the test in platelet defect.

  • Helicobacter pylori: Neurological and Ophthalmological Disorders. Farooq, M. U.; Bhatt, A. // Internet Journal of Neurology;2008, Vol. 9 Issue 2, p7 

    Helicobacter pylori infection has been associated with many intestinal and extraintestinal infections. It has been linked with many neurological and ophthalmological disorders including cerebrovascular diseases, migraine, Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis,...

  • Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients -- follow-up and clinical implications. Petereit, Hela-Felicitas; Reske, Dirk // Cerebrospinal Fluid Research;2005, Vol. 2, p3 

    Background: An intrathecal polyspecific antibody response is a well known finding in multiple sclerosis. However, little is known about the evolution of intrathecal antibodies over time and their impact on the disease progress. Therefore, we focused in this study on the intrathecal polyspecific...

  • THE FUTURE. King, John W. // Annals of Internal Medicine;Aug60, Vol. 53 Issue 2, p419 

    Editorial. Discusses developments in blood grouping and paternity testing. Blood antigen systems; Exploration of antigens present in platelets, leukocytes and plasma.

  • RESEARCH BRIEFS: GM chickenpox/MMR vaccine on the cards.  // GP: General Practitioner;12/1/2003, p11 

    Japanese researchers are planning to develop a genetically modified measles, mumps, rubella and varicella vaccine. They will insert genes encoding the antigens for measles, mumps and rubella into the varicella virus. It will be the first recombinant vaccine against multiple diseases in humans.


Read the Article

Other Topics